Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge.
暂无分享,去创建一个
[1] Lisa Hartling,et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study , 2009, BMJ : British Medical Journal.
[2] K. Dickersin,et al. Metabias: A Challenge for Comparative Effectiveness Research , 2011, Annals of Internal Medicine.
[3] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[4] Peter C Gøtzsche,et al. Bmc Medical Research Methodology Open Access Recommendations by Cochrane Review Groups for Assessment of the Risk of Bias in Studies , 2022 .
[5] J. Ioannidis,et al. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment , 2013, BMJ : British Medical Journal.
[6] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[7] Isabelle Boutron,et al. Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study , 2011, Annals of Internal Medicine.
[8] G. Guyatt,et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. , 2010, JAMA.
[9] Ethan M Balk,et al. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials , 2012, Annals of Internal Medicine.